Psoriasis - Pipeline Assessment and Market Forecasts to 2017 now available at SandlerResearch by Market Research

Original Source: Psoriasis Market

Buy Now: Market Research

Dallas, TX: SandlerResearch announce it will carry Psoriasis – Pipeline Assessment and Market Forecasts to 2017Market Research Report in its Store.

GlobalData, the industry analysis specialist, has released its new report, “Psoriasis – Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global psoriasis market. The report identifies the key trends shaping and driving the global psoriasis market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global psoriasis sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData estimates the global psoriasis therapeutics market to be valued at $2.7 billion in 2009. It is expected to grow with a Compound Annual Growth Rate (CAGR) of approximately 4.73% from $2.7 billion in 2009 to $3.9 billion by 2017. This growth is primarily attributed to increased competition among the existing products and also a strong pipeline with more emerging therapies. The current market is crowded with biologics and also topical treatments for psoriasis. The pipeline is also strong with biologics, as well as several other treatments for mild to moderate psoriasis. With the increased uptake of biologics and increased awareness of the disease in patients leading to increased treatment seeking rates in the early stages of the disease, the psoriasis therapeutics market is expected to generate large revenues

Scope

The report provides information on the key drivers and challenges of the psoriasis market. Its scope includes:

- Annualized global psoriasis market revenues data from 2001 to 2009, forecast for eight years to 2017.

- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as TNF-alpha inhibitors, IL inhibitors contribute, corticosteroid, vitamin D, monoclonal antibodies, Growth Factor Beta 1 (TGF-B1) inhibitor peptides, Toll-like receptor (TLR) modulators, STAT pathway inhibitors, retinoic acid agents, Protein Kinase C (PKC) inhibitors, NF-kB inhibitors, naturally occurring proteins, Kv1.3 blockers, IL-22 modulators, IL-2 antagonists, cytokine modulators, antimetabolites, PDE-4 Inhibitors, JAK-3 Inhibitors and IL-23 antibodies.

- Analysis of the current and future competition in the global psoriasis market. Key market players covered are Glaxao Smit Kline, Leo Pharma, Bristol-Myer Squibb, Novartis and Abott laboratories.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the psoriasis therapeutics market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to:

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global psoriasis market.

- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global psoriasis market in future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

- What's the next big thing in the global psoriasis market landscape? – Identify, understand and capitalize.

Browse complete Report on: Psoriasis – Pipeline Assessment and Market Forecasts to 2017

http://www.sandlerresearch.org/reports/41341-psoriasis-pipeline-assessment-and-market-forecasts-to-2017.html

1 Table of contents 3

1.1 List of Tables 5

1.2 List of Figures 5

2 Psoriasis: Introduction 6

2.1 Overview 6

2.2 GlobalData Pipeline Report Guidance 6

3 Global Psoriasis Therapeutics Market: Market Characterization 7

3.1 Overview 7

3.2 Psoriasis Therapeutics Market Size 7

3.3 Psoriasis Therapeutics Market Forecast and CAGR 8

3.4 Drivers and Barriers for Psoriasis Therapeutics Market 10

3.4.1 Drivers for Psoriasis Therapeutics Market 10

3.4.2 Barriers for Psoriasis Therapeutics Market 10

3.5 Opportunity and Unmet Need 11

3.6 Key Takeaway 12

4 Psoriasis Therapeutics Market: Competitive Assessment 13

4.1 Overview 13

4.2 Strategic Competitor Assessment 13

4.3 Product Profile for the Major Marketed Products in Psoriasis Therapeutics Market 14

4.3.1 Enbrel (etanercept) 14

4.3.2 Humira (adalimumab) 16

4.3.3 Amevive (alefacept) 17

4.3.4 Remicade (infliximab) 18

4.3.5 Stelara (ustekinumab, CNTO1275) 20

4.3.6 Clobex (clobetasol propionate) 21

4.3.7 Tazorac (tazarotene, Avage) 23

4.3.8 Dovonex (calcipotriene) 24

4.4 Other Marketed Products for Psoriasis (Generics) 26

4.4.1 Neoral (cyclosporine) 26

4.5 Key Takeaway 26

5 Psoriasis Therapeutics Market: Pipeline Assessment 27

5.1 Overview 27

5.2 Strategic Pipeline Assessment 27

5.2.1 Technology Trends Analytic Framework 27

5.3 Molecule Profile for Promising Drugs for Psoriasis under Clinical Development 30

5.3.1 Voclosporin (LX211, LUVENIQ, ISA-247) 31

5.3.2 ABT-874 (J-695, Briakinumab) 32

5.3.3 CF-101 33

5.3.4 Orencia (abatacept, CTLA4-Ig, BMS-188667) 33

5.3.5 Cimzia (CDP870 certolizumab pegol) 34

5.3.6 Apremilast (CC10004, ACR20) 35

5.3.7 INCB18424 36

5.4 Psoriasis Therapeutics Market – Clinical Pipeline by Mechanism of Action 36

5.5 Psoriasis Therapeutics Pipeline – Pipeline by Clinical Phases of Development 37

5.5.1 Psoriasis Therapeutics – Phase III Clinical Pipeline 38

5.5.2 Psoriasis Therapeutics – Phase II Clinical Pipeline 39

5.5.3 Psoriasis Therapeutics – Phase I Clinical Pipeline 41

5.5.4 Psoriasis Therapeutics – Preclinical Pipeline 42

5.5.5 Psoriasis Therapeutics – Discovery Pipeline 43

5.6 Key Takeaway 43

6 Psoriasis Therapeutics Market: Implications for Future Market Competition 44

7 Psoriasis Therapeutics Market: Future Players in the Psoriasis Therapeutics Market 46

7.1 Introduction 46

7.2 GlaxoSmithKline plc 47

7.2.1 Overview 47

7.2.2 Psoriasis Product Portfolio 47

7.3 Bristol-Myers Squibb 48

7.3.2 Psoriasis Product Portfolio 48

7.4 Leo Pharma 49

7.4.1 Overview 49

7.5 Novartis 50

7.5.2 Psoriasis Product Portfolio 51

7.6 Abbott Laboratories 52

7.6.2 Psoriasis Product Portfolio 52

8 Psoriasis Therapeutics Market: Appendix 54

8.1 Market Definitions 54

8.2 Abbreviations 54

8.3 Research Methodology 56

8.3.1 Coverage 56

8.3.2 Secondary Research 56

8.3.3 Forecasting 56

8.3.4 Primary Research 59

8.3.5 Expert Panel Validation 59

8.4 Contact Us 59

8.5 Disclaimer 59

8.6 Sources 60

Browse all Healthcare Market Research Reports on:

http://www.sandlerresearch.org/market-research/healthcare/

Browse all GlobalData Market Research Reports on:

http://www.sandlerresearch.org/publishers/globaldata/

Browse all Newly Published Market Research Reports on:

http://www.sandlerresearch.org/LatestReport.aspx

Related Reports:

Influenza Vaccines – Pipeline Assessment and Market Forecasts to 2017

http://www.sandlerresearch.org/reports/36584-influenza-vaccines-pipeline-assessment-and-market-forecasts-to-.html

Acute Myeloid Leukemia (AML) – Pipeline Assessment and Market Forecasts to 2017

http://www.sandlerresearch.org/reports/39673-acute-myeloid-leukemia-aml-pipeline-assessment-and-market-for.html

Head and Neck Cancer – Pipeline Assessment and Market Forecast to 2017

http://www.sandlerresearch.org/reports/36585-head-and-neck-cancer-pipeline-assessment-and-market-forecast-to.htm

Rheumatoid Arthritis – Pipeline Assessment and Market Forecasts to 2017

http://www.sandlerresearch.org/reports/37160-rheumatoid-arthritis-pipeline-assessment-and-market-forecasts-t.html

Systemic Lupus Erythematosus – Pipeline Assessment and Market Forecasts to 2017

http://www.sandlerresearch.org/reports/37161-systemic-lupus-erythematosus-pipeline-assessment-and-market-for.html

About Us:

Sandler Research houses a comprehensive online library of more than 10,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe.

Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.

We also provide 24/7 online and offline support to our customers.

Contact:

Ms. Sunita

7557 Rambler road,

Suite 727, Dallas, TX 75231

Tel: +1-888-989-8004

Website: http://www.sandlerresearch.org

Blog: http://sandlerresearch.blogspot.com

Sandler Research houses a comprehensive online library of more than 10,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe. Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools.

Article Source: ArticleSnatch Free Article Directory